Clinical Testing of the Radiosensitizer Ro 07-0582: Experience with Multiple Doses

Overview

Journal Br J Cancer

Specialty Oncology

Date 1977 May 1

PMID 861146

Citations 64

Authors

S Dische

M I Saunders

M E Lee

G E Adams

I R Flockhart

Affiliations

Soon will be listed here.

Abstract

The hypoxic cell radiosensitizer, Ro 07-0582, has now been given in multiple doses to 16 patients. They have received a total of 15-51 g in 3-20 doses. Immediate tolerance was good, and satisfactory plasma levels of the drug were consistently obtained. Neurotoxicity was, however, troublesome: convulsions occurred in the patient given the highest dose, and there was peripheral neuropathy in 11 cases. Tumour concentrations similar to those in plasma were obtained in human tumours, in contrast to the findings in mouse tumours where concentrations are usually below 40% of plasma levels. In the treatment of human tumours, a lower dose of Ro 07-0582 should give useful hypoxic cell sensitization. Although the total dose of Ro 07-0582 must be limited, there is a real prospect that it will give benefit in clinical radiotherapy.

Citing Articles

Targeting Hypoxia: Revival of Old Remedies.

Vilaplana-Lopera N, Besh M, Moon E Biomolecules. 2021; 11(11).

PMID: 34827602 PMC: 8615589. DOI: 10.3390/biom11111604.

Application of Radiosensitizers in Cancer Radiotherapy.

Gong L, Zhang Y, Liu C, Zhang M, Han S Int J Nanomedicine. 2021; 16:1083-1102.

PMID: 33603370 PMC: 7886779. DOI: 10.2147/IJN.S290438.

On-chip combined radiotherapy and chemotherapy testing on soft-tissue sarcoma spheroids to study cell death using flow cytometry and clonogenic assay.

Patra B, Lafontaine J, Bavoux M, Zerouali K, Glory A, Ahanj M Sci Rep. 2019; 9(1):2214.

PMID: 30778138 PMC: 6379442. DOI: 10.1038/s41598-019-38666-9.

Hypoxia-targeted drug delivery.

Sharma A, Arambula J, Koo S, Kumar R, Singh H, Sessler J Chem Soc Rev. 2018; 48(3):771-813.

PMID: 30575832 PMC: 6361706. DOI: 10.1039/c8cs00304a.

Multidirectional Efficacy of Biologically Active Nitro Compounds Included in Medicines.

Olender D, Zwawiak J, Zaprutko L Pharmaceuticals (Basel). 2018; 11(2).

PMID: 29844300 PMC: 6027522. DOI: 10.3390/ph11020054.

References

Dische S, Senanayake F . Radiotherapy using hyperbaric oxygen in the palliation of carcinoma of colon and rectum. Clin Radiol. 1972; 23(4):512-8. DOI: 10.1016/s0009-9260(72)80032-1. View

Choi C, Suit H . Evaluation of rapid radiation treatment schedules utilizing two treatment sessions per day. Radiology. 1975; 116(3):703-7. DOI: 10.1148/116.3.703. View

Urtasun R, Band P, Chapman J, Feldstein M, Mielke B, Fryer C . Radiation and high-dose metronidazole in supratentorial glioblastomas. N Engl J Med. 1976; 294(25):1364-7. DOI: 10.1056/NEJM197606172942503. View

Coxon A, Pallis C . Metronidazole neuropathy. J Neurol Neurosurg Psychiatry. 1976; 39(4):403-5. PMC: 492292. DOI: 10.1136/jnnp.39.4.403. View

Johnson R, Gomer C, Ambrus J, Pearce J, Boyle D . Letter: An investigation of the pharmacological and radiosensitizing effects of the 2-nitroimidazole Ro-07-0582 in primates. Br J Radiol. 1976; 49(579):294-5. DOI: 10.1259/0007-1285-49-579-294-b. View

Ingham H, Selkon J, Hale J . The antibacterial activity of netronidazole. J Antimicrob Chemother. 1975; 1(4):355-61. DOI: 10.1093/jac/1.4.355. View

THOMLINSON R, Dische S, Gray A, Errington L . Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976; 27(2):167-74. DOI: 10.1016/s0009-9260(76)80139-0. View

Gray A, Dische S, Adams G, Flockhart I, Foster J . Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol. 1976; 27(2):151-7. DOI: 10.1016/s0009-9260(76)80137-7. View

Dische S, Gray A, Zanelli G . Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol. 1976; 27(2):159-66. DOI: 10.1016/s0009-9260(76)80138-9. View

10.

Adams G, Flockhart I, Smithen C, Stratford I, Wardman P, Watts M . Electron-affinic sensitization. VII. A correlation between structures, one-electron reduction potentials, and efficiencies of nitroimidazoles as hypoxic cell radiosensitizers. Radiat Res. 1976; 67(1):9-20. View

11.

Foster J, Flockhart I, Dische S, Gray A, LENOX-SMITH I, Smithen C . Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. Br J Cancer. 1975; 31(6):679-83. PMC: 2009479. DOI: 10.1038/bjc.1975.115. View

12.

Svoboda V . Radiotherapy by several sessions a day. Br J Radiol. 1975; 48(566):131-3. DOI: 10.1259/0007-1285-48-566-131. View